Drug developers, public to benefit from PH Ivermectin clinical trials ‘if results are good', says DOST

Philippines News News

Drug developers, public to benefit from PH Ivermectin clinical trials ‘if results are good', says DOST
Philippines Latest News,Philippines Headlines
  • 📰 manilabulletin
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

Bracing for “good results,” DOST said that the drug developers and the public are expected to benefit from the country’s clinical trials seeking to assess the efficacy, safety, and effect on drug Ivermectin in asymptomatic and COVID-19 patients

Bracing for “good results,” the Department of Science and Technology said Thursday, Oct. 21, that the drug developers and the public are expected to benefit from the country’s clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease patients confined in isolation facilities.

“The project is working with its own formulation to comply with the existing standards for double-blind, placebo-controlled trials.” “We would like to reiterate that the compounded capsules to be used solely for the purpose of clinical trials will adhere to Good Manufacturing Practice and Compounding Practice, and will be subjected to tests for raw materials and finished product,” said Dr. Yolanda Robles, lead of the Pharmacy team of the ivermectin trials.

The Department of Health and the Food and Drug Administration are not yet recommending the use of Ivermectin for the treatment of COVID-19 due to insufficient scientific evidence.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

manilabulletin /  🏆 25. in PH

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

DOST-FNRI partners with UP-NIH for research on nutrition, agingDOST-FNRI partners with UP-NIH for research on nutrition, agingThe Department of Science and Technology-Food and Nutrition Research Institute (DOST-FNRI) forged partnership with the University of the Philippines Manila-National Institutes of Health (UP-NIH) to pursue research on nutrition and aging.
Read more »

DOST to conduct study on VCO’s effectivity vs COVID-19DOST to conduct study on VCO’s effectivity vs COVID-19The DOST is set to conduct a study seeking to explore whether or not the virgin coconut oil (VCO), known for its antiviral and antimicrobial properties can prevent COVID-19.
Read more »

PH Red Cross' COVID-19 test results 'valid, reliable', says RITMPH Red Cross' COVID-19 test results 'valid, reliable', says RITMThe Research Institute on Tropical Medicine (RITM) said that the COVID-19 test results produced by the Philippine Red Cross (PRC) were found “valid and reliable.”
Read more »

Rama to meet WestVac reps on ThursdayRama to meet WestVac reps on ThursdayCEBU CITY, Philippines -- Cebu City Acting Mayor Michael Rama will be meeting the representatives of WestVac Biopharma Co. Ltd. on October 21, 2021, to discuss issues regarding clinical trials
Read more »

Belgian police break up cocaine network, arrest 27Belgian officials announced they had broken up a cocaine smuggling gang, arresting 27 people in a series of raids during which they seized drugs, guns and luxury goods — including horses. | AFP
Read more »

Molnupiravir won’t cost $700 in PH; to be accessible to public----pharma execMolnupiravir won’t cost $700 in PH; to be accessible to public----pharma execThe price of the new antiviral drug molnupiravir, a potential treatment for COVID-19, will not be that expensive and will be accessible to the people, a local official of MSD Pharmaceuticals said.
Read more »



Render Time: 2025-04-21 19:11:37